Clinical Trials Logo

Clinical Trial Summary

Post-traumatic seizures can appear frequently after a severe traumatic brain injury. Two types of seizures are usually identified: early seizures during the week following the trauma and late epilepsy afterward. Several antiepileptic drugs are usually used to prevent early seizures but no treatment has demonstrated any preventive effect against late epilepsy. Levetiracetam is an antiepileptic drug usually used for the treatment of epileptic patients and has pharmacologic properties that could also be interesting for the prevention of post-traumatic epilepsy.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00566046
Study type Interventional
Source Rennes University Hospital
Contact
Status Terminated
Phase Phase 3
Start date November 2007
Completion date May 2010

See also
  Status Clinical Trial Phase
Recruiting NCT03999164 - Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy Phase 1
Recruiting NCT05353452 - Collaborative Care in Posttraumatic Epilepsy N/A